DSpace Repository

COVID-19 vaccine equity: a health systems and policy perspective.

Show simple item record

dc.contributor.author Van De Pas, Remco
dc.contributor.author Widdowson, Marc-Alain
dc.contributor.author Ravinetto, Raffaella
dc.contributor.author N Srinivas, Prashanth
dc.contributor.author Ochoa Woodell, Theresa Jean
dc.contributor.author Fofana, Thierno Oumar
dc.contributor.author Van Damme, Wim
dc.date.accessioned 2021-12-12T20:24:56Z
dc.date.available 2021-12-12T20:24:56Z
dc.date.issued 2021
dc.identifier.uri https://hdl.handle.net/20.500.12866/10244
dc.description.abstract INTRODUCTION: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. AREAS COVERED: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. EXPERT OPINION: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter en_US
dc.language.iso eng
dc.publisher Taylor and Francis
dc.relation.ispartofseries Expert Review of Vaccines
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject low-income countries en_US
dc.subject ACT-A en_US
dc.subject capacity development en_US
dc.subject COVID-19 pandemic en_US
dc.subject research & development ecosystem en_US
dc.subject Tanahashi health systems framework en_US
dc.subject technology transfer en_US
dc.subject TRIPS en_US
dc.subject vaccine equity en_US
dc.title COVID-19 vaccine equity: a health systems and policy perspective. en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1080/14760584.2022.2004125
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#1.06.03
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.01.03
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.01.05
dc.relation.issn 1744-8395


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


Browse

My Account

Statistics